160
Participants
Start Date
February 1, 2018
Primary Completion Date
May 1, 2025
Study Completion Date
February 1, 2026
Collection of blood and bone marrow
Collection of blood and bone marrow in order to identify epigenetic abnormalities and their consequences in surviving CML cells after 3 months of TKI treatment
RECRUITING
CHU Clermont-Ferrand, Clermont-Ferrand
RECRUITING
CHU Annecy-Genevois, Annecy
RECRUITING
Institut Bergonié, Bordeaux
RECRUITING
CHU Caen, Caen
RECRUITING
CHU Grenoble Alpes, Grenoble
RECRUITING
CHU Lille, Lille
RECRUITING
Centre Léon Bérard, Lyon
RECRUITING
Hospices Civils de Lyon, Lyon
RECRUITING
CHU Nancy, Nancy
RECRUITING
CHU Nice, Nice
RECRUITING
Hôpital Bicêtre, Paris
RECRUITING
Hôpital Henri Mondor, Paris
RECRUITING
Hôpital Paul Brousse, Paris
RECRUITING
Hôpital Saint Louis, Paris
RECRUITING
CHU Saint-Etienne, Saint-Etienne
RECRUITING
CHU Versailles, Versailles
Institut Paoli-Calmettes
OTHER
CHRU Lille, hematology department
UNKNOWN
CH Annecy Genevois
OTHER
Institut Bergonié Bordeaux, hematology department
UNKNOWN
Central Hospital, Nancy, France
OTHER
CHU Saint-Etienne, hematology department
UNKNOWN
Institut Universitaire du Cancer de Toulouse
OTHER
CHU Caen, hematology department
UNKNOWN
CHU Nice, hematology department
UNKNOWN
Hospices Civils de Lyon
OTHER
AP-HP, hematology department
UNKNOWN
AP-HP Hôpital Henri-Mondor, hematology department
UNKNOWN
Versailles Hospital
OTHER
Centre Leon Berard
OTHER
University Hospital, Grenoble
OTHER
University Hospital, Clermont-Ferrand
OTHER